|
|
|
Volumn 146, Issue 1, 2002, Pages 24-27
|
|
Rivastigmine in Alzheimer's disease; evaluation of the first experiences and of structured measurement of efficacy;Rivastigmine bij de ziekte van Alzheimer; evaluatie van de eerste ervaringen en van gestructureerde effectmeting
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RIVASTIGMINE;
ADULT;
AGED;
ALZHEIMER DISEASE;
ARTICLE;
BEHAVIOR;
CLINICAL PRACTICE;
COGNITION;
CONTROLLED STUDY;
DAILY LIFE ACTIVITY;
DISEASE COURSE;
DOSE RESPONSE;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
FUNCTIONAL ASSESSMENT;
GASTROINTESTINAL DISEASE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ACTIVITIES OF DAILY LIVING;
AGED;
AGED, 80 AND OVER;
ALZHEIMER DISEASE;
CARBAMATES;
CHOLINESTERASE INHIBITORS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEUROPROTECTIVE AGENTS;
PATIENT DROPOUTS;
PHENYLCARBAMATES;
PSYCHIATRIC STATUS RATING SCALES;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
|
EID: 0037021819
PISSN: 00282162
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (8)
|
